From his time in the industry before the contemporary good manufacturing practice (cGMP), senior drug substance consultant at DSI, a ProductLife Group company, Dave Adams quickly grasped the necessity ...
AbbVie’s $100 billion splurge on domestic manufacturing and R&D is continuing to come into focus, this time with a $380 million investment in two new active pharmaceutical ingredient (API) manu | The ...
AbbVie is investing $195m to strengthen domestic active pharmaceutical ingredient (API) production within the US, with the expansion of its manufacturing plant in North Chicago, Illinois. This ...
ST. LOUIS--(BUSINESS WIRE)--The API Innovation Center (APIIC) today announced that it has been awarded funding by the Administration for Strategic Preparedness and Response’s (ASPR) Center for ...
11d
Top Pharmaceutical API Manufacturer Navigates Shifts in Global Drug Supply and Regulatory Landscape
According to multiple recent market analyses, the global API market is experiencing steady growth. One comprehensive forecast ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results